CureVac (CVAC) has released an update.
CureVac N.V. reported increasing revenues but also a growing operating loss in its latest interim condensed consolidated financial statements for the six months ending June 30, 2024, compared to the same period in 2023. The net loss per share has also increased, indicating a potential concern for investors. The company’s total assets have decreased, reflecting changes in various balance sheet items, including a significant drop in cash and cash equivalents.
For further insights into CVAC stock, check out TipRanks’ Stock Analysis page.
